Intensity Therapeutics, Inc. SEC filings INTS
Intensity Therapeutics, Inc. has 246 filings in SEC EDGAR's recent list, going back to Jan 18, 2013. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2026 | Aug 11, 2026 |
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| S-8 | Employee stock plan registration | Jul 8, 2026 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 16, 2026 | Jun 16, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| ARS | Annual report to shareholders | Apr 30, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| DEF 14A | Proxy statement | Apr 30, 2026 | Apr 30, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 27, 2026 | Mar 27, 2026 |
| 10-K | Annual report | Mar 27, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Other events
|
Mar 23, 2026 | Mar 23, 2026 |
| 424B5 | Prospectus supplement | Mar 23, 2026 | — |
| 8-K |
Current report
Other events
|
Mar 6, 2026 | Mar 5, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 5, 2026 | Mar 5, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Feb 13, 2026 | Feb 13, 2026 |
| S-8 | Employee stock plan registration | Jan 23, 2026 | — |
| 8-K |
Current report
Listing notice
|
Dec 5, 2025 | Dec 4, 2025 |
| 8-K |
Current report
Other events
|
Dec 4, 2025 | Dec 4, 2025 |
| 424B5 | Prospectus supplement | Dec 4, 2025 | — |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 424B5 | Prospectus supplement | Nov 3, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Oct 31, 2025 | Oct 30, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Oct 23, 2025 | Oct 22, 2025 |
| 8-K |
Current report
Other events
|
Sep 10, 2025 | Sep 10, 2025 |
| DEFA14A | Additional proxy material | Sep 9, 2025 | — |
| DEF 14A | Proxy statement | Sep 9, 2025 | Sep 9, 2025 |
| PRE 14A | Preliminary proxy statement | Aug 28, 2025 | Aug 28, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Aug 12, 2025 | Aug 8, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Other events
|
Aug 4, 2025 | Aug 4, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jul 18, 2025 | Jul 17, 2025 |
| S-8 | Employee stock plan registration | Jun 27, 2025 | — |
| 424B5 | Prospectus supplement | Jun 18, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jun 13, 2025 | Jun 11, 2025 |
| 424B5 | Prospectus supplement | Jun 12, 2025 | — |
| FWP | Free writing prospectus | Jun 11, 2025 | — |
| 424B5 | Prospectus supplement | Jun 11, 2025 | — |
| 424B5 | Prospectus supplement | Jun 11, 2025 | — |
| 8-K |
Current report
Listing notice
|
Jun 6, 2025 | Jun 6, 2025 |
| ARS | Annual report to shareholders | Jun 2, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Jun 2, 2025 | — |
| DEF 14A | Proxy statement | Jun 2, 2025 | Jun 2, 2025 |
| 8-K |
Current report
Listing notice
|
May 20, 2025 | May 19, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 25, 2025 | Apr 24, 2025 |
| 424B4 | Prospectus | Apr 25, 2025 | — |
| EFFECT | Filing | Apr 24, 2025 | — |
| S-1/A | Amended registration statement | Apr 24, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 23, 2025 | Apr 22, 2025 |
| FWP | Free writing prospectus | Apr 23, 2025 | — |
| CORRESP | Letter to the SEC | Apr 22, 2025 | — |
| S-1 | Registration statement | Apr 22, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 2, 2025 | — |
| DRS | Filing | Mar 28, 2025 | — |
| 8-K |
Current report
Results of operations
|
Mar 13, 2025 | Mar 13, 2025 |
| 10-K | Annual report | Mar 13, 2025 | Dec 31, 2024 |
| UPLOAD | Letter from the SEC | Jan 21, 2025 | — |
| CORRESP | Letter to the SEC | Jan 7, 2025 | — |
| UPLOAD | Letter from the SEC | Dec 26, 2024 | — |
| 424B3 | Prospectus | Dec 20, 2024 | — |
| EFFECT | Filing | Dec 19, 2024 | — |
| CORRESP | Letter to the SEC | Dec 17, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 17, 2024 | — |
| S-1 | Registration statement | Dec 13, 2024 | — |
| D | Filing | Dec 5, 2024 | — |
| 424B5 | Prospectus supplement | Nov 22, 2024 | — |
| 8-K |
Current report
Material agreement, Other events
|
Nov 22, 2024 | Nov 21, 2024 |
| 424B5 | Prospectus supplement | Nov 20, 2024 | — |
| 8-K |
Current report
Results of operations
|
Nov 13, 2024 | Nov 13, 2024 |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 23, 2024 | Oct 21, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jul 17, 2024 | Jul 17, 2024 |
| EFFECT | Filing | Jul 11, 2024 | — |
| EFFECT | Filing | Jul 11, 2024 | — |
| CORRESP | Letter to the SEC | Jul 9, 2024 | — |
| CORRESP | Letter to the SEC | Jul 9, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 8, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 8, 2024 | — |
| S-8 | Employee stock plan registration | Jul 3, 2024 | — |
| S-3 | Shelf registration | Jul 3, 2024 | — |
| 8-K |
Current report
Material agreement
|
Jul 3, 2024 | Jul 3, 2024 |
| S-3 | Shelf registration | Jul 3, 2024 | — |
| DEFA14A | Additional proxy material | Jun 4, 2024 | — |
| DEF 14A | Proxy statement | Jun 4, 2024 | Jun 4, 2024 |
| ARS | Annual report to shareholders | Jun 4, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Officer or director change
|
May 24, 2024 | May 21, 2024 |
| 8-K |
Current report
Officer or director change
|
May 15, 2024 | May 14, 2024 |
| 8-K |
Current report
Material agreement
|
May 10, 2024 | May 6, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Listing notice
|
Apr 19, 2024 | Apr 18, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 14, 2024 | Mar 14, 2024 |
| 10-K | Annual report | Mar 14, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Officer or director change
|
Feb 7, 2024 | Feb 6, 2024 |
| 8-K |
Current report
Officer or director change
|
Dec 12, 2023 | Dec 11, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Nov 22, 2023 | Nov 21, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2023 | Nov 13, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 5, 2023 | Sep 5, 2023 |
| S-8 | Employee stock plan registration | Aug 22, 2023 | — |
| 10-Q/A | Amended quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2023 | Aug 14, 2023 |
| 8-K |
Current report
Other events
|
Jul 10, 2023 | Jul 10, 2023 |
| 8-K |
Current report
Material agreement, Bylaw or fiscal year change, Regulation FD disclosure
|
Jul 5, 2023 | Jun 29, 2023 |
| 424B4 | Prospectus | Jun 30, 2023 | — |
| CERT | Filing | Jun 30, 2023 | — |
| SEC STAFF LETTER | Filing | Jun 29, 2023 | — |
| EFFECT | Filing | Jun 29, 2023 | — |
| S-1MEF | Registration statement | Jun 29, 2023 | — |
| S-1/A | Amended registration statement | Jun 29, 2023 | — |
| CORRESP | Letter to the SEC | Jun 27, 2023 | — |
| CORRESP | Letter to the SEC | Jun 27, 2023 | — |
| FWP | Free writing prospectus | Jun 23, 2023 | — |
| S-1/A | Amended registration statement | Jun 23, 2023 | — |
| CORRESP | Letter to the SEC | Jun 9, 2023 | — |
| S-1/A | Amended registration statement | Jun 9, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 7, 2023 | — |
| FWP | Free writing prospectus | Jun 1, 2023 | — |
| S-1/A | Amended registration statement | May 18, 2023 | — |
| CORRESP | Letter to the SEC | Feb 14, 2023 | — |
| CORRESP | Letter to the SEC | Feb 14, 2023 | — |
| FWP | Free writing prospectus | Feb 13, 2023 | — |
| CORRESP | Letter to the SEC | Feb 9, 2023 | — |
| CORRESP | Letter to the SEC | Feb 9, 2023 | — |
| FWP | Free writing prospectus | Feb 9, 2023 | — |
| CORRESP | Letter to the SEC | Feb 8, 2023 | — |
| CORRESP | Letter to the SEC | Feb 8, 2023 | — |
| CORRESP | Letter to the SEC | Feb 6, 2023 | — |
| CORRESP | Letter to the SEC | Feb 6, 2023 | — |
| CORRESP | Letter to the SEC | Jan 27, 2023 | — |
| S-1/A | Amended registration statement | Jan 27, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 23, 2023 | — |
| FWP | Free writing prospectus | Jan 13, 2023 | — |
| S-1/A | Amended registration statement | Jan 13, 2023 | — |
| CORRESP | Letter to the SEC | Nov 9, 2022 | — |
| CORRESP | Letter to the SEC | Nov 9, 2022 | — |
| CORRESP | Letter to the SEC | Nov 3, 2022 | — |
| CORRESP | Letter to the SEC | Nov 3, 2022 | — |
| CORRESP | Letter to the SEC | Nov 2, 2022 | — |
| S-1/A | Amended registration statement | Nov 2, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 31, 2022 | — |
| SEC STAFF LETTER | Filing | Oct 18, 2022 | — |
| CORRESP | Letter to the SEC | Oct 13, 2022 | — |
| CORRESP | Letter to the SEC | Oct 13, 2022 | — |
| CORRESP | Letter to the SEC | Oct 13, 2022 | — |
| CORRESP | Letter to the SEC | Oct 13, 2022 | — |
| SEC STAFF LETTER | Filing | Oct 13, 2022 | — |
| CORRESP | Letter to the SEC | Oct 11, 2022 | — |
| CORRESP | Letter to the SEC | Oct 11, 2022 | — |
| CORRESP | Letter to the SEC | Oct 3, 2022 | — |
| S-1/A | Amended registration statement | Oct 3, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 29, 2022 | — |
| FWP | Free writing prospectus | Sep 20, 2022 | — |
| S-1/A | Amended registration statement | Sep 20, 2022 | — |
| CORRESP | Letter to the SEC | May 16, 2022 | — |
| S-1/A | Amended registration statement | May 16, 2022 | — |
| UPLOAD | Letter from the SEC | Apr 28, 2022 | — |
| SEC STAFF LETTER | Filing | Apr 26, 2022 | — |
| FWP | Free writing prospectus | Apr 20, 2022 | — |
| S-1/A | Amended registration statement | Apr 20, 2022 | — |
| FWP | Free writing prospectus | Jan 7, 2022 | — |
| S-1/A | Amended registration statement | Jan 7, 2022 | — |
| FWP | Free writing prospectus | Dec 16, 2021 | — |
| CORRESP | Letter to the SEC | Dec 10, 2021 | — |
| CORRESP | Letter to the SEC | Dec 10, 2021 | — |
| CORRESP | Letter to the SEC | Dec 9, 2021 | — |
| S-1/A | Amended registration statement | Dec 9, 2021 | — |
| UPLOAD | Letter from the SEC | Dec 9, 2021 | — |
| S-1/A | Amended registration statement | Dec 8, 2021 | — |
| CORRESP | Letter to the SEC | Dec 7, 2021 | — |
| CORRESP | Letter to the SEC | Dec 7, 2021 | — |
| 8-A12B/A | Amendment no. 1 to form 8-a12b | Dec 2, 2021 | — |
| 8-A12B | For registration of certain classes | Nov 30, 2021 | — |
| FWP | Free writing prospectus | Nov 24, 2021 | — |
| CORRESP | Letter to the SEC | Nov 18, 2021 | — |
| S-1/A | Amended registration statement | Nov 18, 2021 | — |
| UPLOAD | Letter from the SEC | Nov 16, 2021 | — |
| CORRESP | Letter to the SEC | Nov 12, 2021 | — |
| S-1/A | Amended registration statement | Nov 12, 2021 | — |
| UPLOAD | Letter from the SEC | Nov 9, 2021 | — |
| SEC STAFF LETTER | Filing | Nov 8, 2021 | — |
| CORRESP | Letter to the SEC | Oct 28, 2021 | — |
| S-1 | Registration statement | Oct 28, 2021 | — |
| UPLOAD | Letter from the SEC | Oct 18, 2021 | — |
| DRS | Filing | Sep 20, 2021 | — |
| D | Filing | Jun 12, 2015 | — |
| D/A | Filing | Dec 2, 2014 | — |
| D/A | Filing | Feb 11, 2014 | — |
| D | Filing | Jan 18, 2013 | — |
Showing 198 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- INTS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Shelton, CT
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1567264
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.